Form 8-K - Current report:
SEC Accession No. 0001193125-26-261658
Filing Date
2026-06-08
Accepted
2026-06-08 16:01:05
Documents
11
Period of Report
2026-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d116098d8k.htm   iXBRL 8-K 34820
  Complete submission text file 0001193125-26-261658.txt   145962

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stro-20260605.xsd EX-101.SCH 3179
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20260605_lab.xml EX-101.LAB 17232
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20260605_pre.xml EX-101.PRE 10811
14 EXTRACTED XBRL INSTANCE DOCUMENT d116098d8k_htm.xml XML 3500
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 261072496
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)